featured
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study
Clin. Gastroenterol. Hepatol. 2022 Jul 01;20(7)1516-1524.e2, J Ai, J Wang, D Liu, H Xiang, Y Guo, J Lv, Q Zhang, J Li, X Zhang, Q Li, J Liang, X Guo, Y Feng, L Liu, X Zhang, W Qin, X Wang, W Rao, Q Zhang, Q Tian, Y Zhang, F Xie, S Jiang, Y Yan, Y Qiu, H Wu, Z Hou, N Zhang, A Zhang, J Ji, J Yang, J Huang, Z Zhao, Y Gu, L Bian, Z Zhang, S Zou, H Ji, G Ge, X Du, A Hou, Y Zhu, Q Cong, J Xu, H Zu, Y Wang, Z Yan, X Yan, Y BianBa, Q Ci, L Zhang, S Yang, X Gao, L Zhong, S He, C Liu, Y Huang, Y Liu, D Xu, Q Zhu, X Xu, M Lv, W Zhang, X QiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.